Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Nowadays vaccination of the population living in the endemic regions and widespread implementation of the potent therapies for the emergency prophylaxis and treatment into the clinical practice are regarded as the basic efficient and cost-effective measures for Ebola epidemic spread control. Objecti...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	A. A. Petrov, V. N. Lebedev, T. M. Plekhanova, L. F. Stovba, G. V. Borisevich, O. N. Sidorova, O. V. Chukhralya, S. V. Borisevich
Μορφή:	Άρθρο
Γλώσσα:	Russian
Έκδοση:	Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2015-09-01
Σειρά:	Проблемы особо опасных инфекций
Θέματα:	вирус эбола лекарственные средства экстренная профилактика и лечение вирусспецифические антитела моноклональные антитела малые интерферирующие рнк антисмысловые фосфордиамидатные морфолиновые олигомеры ebola virus hemorrhagic fever medical products emergency prophylaxis and treatment virus-specific antibodies monoclonal antibodies small interfering rna anti-sense phosphordiamidate morpholine oligomers
Διαθέσιμο Online:	https://journal.microbe.ru/jour/article/view/254

Παρόμοια τεκμήρια

Monoclonal Antibodies and Recombinant Proteins for Immune-Diagnostics of Ebola Virus Disease
ανά: E. I. Kazachinskaya, κ.ά.
Έκδοση: (2015-09-01)

“CAMEL” ANTIBODIES: FEATURES OF THEIR STRUCTURE, PREPARATION AND APPLICATION
ανά: Alexey Alekseevich Andreev, κ.ά.
Έκδοση: (2020-06-01)

Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases
ανά: A. A. Petrov, κ.ά.
Έκδοση: (2020-05-01)

New Monoclonal Antibodies for the Diagnosis of Influenza and other Acute Respiratory Viral Infections
ανά: A. A. Sominina, κ.ά.
Έκδοση: (2015-10-01)

Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
ανά: A. V. Philippova, κ.ά.
Έκδοση: (2019-10-01)

Preparations of next generation monoclonal antibodies (issues and prospects)
ανά: Zh. I. Avdeeva, κ.ά.
Έκδοση: (2018-02-01)

SMALL NONCODING RNA AS PERSPECTIVE BIOMARKERS: BIOGENESIS AND THERAPEUTIC STRATIGIES
ανά: V. V. Tiguntsev, κ.ά.
Έκδοση: (2016-06-01)

Obtainment of Monoclonal Antibodies and Prospects of Their Application as Basis for Immunodiagnostic Aids for Crimean-Congo Hemorrhagic Fever Virus Detection
ανά: N. P. Khrapova, κ.ά.
Έκδοση: (2015-03-01)

Safety issues of monoclonal antibodies used in rheumatology
ανά: A. V. Philippova, κ.ά.
Έκδοση: (2020-01-01)

The Molecular Genetic Peculiarities of Genomic Structure of Members of the <i>Ebolavirus</i> Genus
ανά: A. A. Petrov, κ.ά.
Έκδοση: (2015-09-01)

Manufacturing of Hybridomas-Producers of Monoclonal Anti-Bodies to Tularemia Agent Antigens
ανά: O. O. Fomenkov, κ.ά.
Έκδοση: (2015-06-01)

Study of protectivity and antigenicity of vaccine based on ' cultural Asia-1 No.2145/ Tajikistan/2011 FMD Virus
ανά: D. A. Lozovoy, κ.ά.
Έκδοση: (2018-04-01)

Constructing and Medical Trials of a Monoclonal Dot-Immuno-Enzyme Test-System “DIATul-M” for Tularemia Microbe Detection
ανά: N. E. Tereshkina, κ.ά.
Έκδοση: (2013-06-01)

SEROPREVALENCE OF INFECTIOUS BURSAL DISEASE VIRUS IN PRIVATE POULTRY BREEDINGS OF UKRAINE FROM 2014 TO 2016
ανά: А. С. Пастиря, κ.ά.
Έκδοση: (2017-06-01)

Utilization of Immunoblotting in Studies of Epitope Targeting in Monoclonal Antibodies to Melioidosis Agent Antigen 200 kDa
ανά: I. I. Korsakova, κ.ά.
Έκδοση: (2014-12-01)

Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease
ανά: T. E. Sizikova, κ.ά.
Έκδοση: (2015-09-01)

Diagnosis of hepatitis c today and interpretation of infection markers
ανά: T. V. Kozhanova
Έκδοση: (2013-12-01)

Antidiphtheria immunity at children with allergic diseases
ανά: A V Labushkina, κ.ά.
Έκδοση: (2009-12-01)

Pharmacokinetic properties of the preparations of protein origin
ανά: A. A. Soldatov, κ.ά.
Έκδοση: (2018-02-01)

Development of Immune-Chromatographic Monoclonal Test-System for the Detection of <i>Yersinia pseudotuberculosis</i>, Serogroup I
ανά: N. V. Bogacheva, κ.ά.
Έκδοση: (2016-06-01)

Validation of the technique aimed at the determination of FMD antibodies in liquid phase blocking sandwich Elisa
ανά: N. N. Lugovskaya, κ.ά.
Έκδοση: (2018-04-01)

Возможности сочетания иммунотерапии с лучевой терапией в лечении больных неоперабельным местно-распространённым немелкоклеточным раком легкого. Обзор литературы.
Έκδοση: (2021-06-01)

Сравнительная эффективность и безопасность применения препаратов моноклональных антител к ИЛ-6 у пациентов с новой коронавирусной инфекцией COVID-19 тяжелого течения. Ретроспективное когортное исследование
ανά: С. С. Бобкова, κ.ά.
Έκδοση: (2021-03-01)

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review
ανά: D. L. Klabukova, κ.ά.
Έκδοση: (2018-07-01)

Метод РНК-интерференции в защите растений от насекомых-вредителей
ανά: Владимир Сергеевич Журавлев, κ.ά.
Έκδοση: (2022-04-01)

Validation of the XTT-test for assessing the antiproliferative activity of biologics on the basis of monoclonal antibodies
ανά: I. V. Lyagoskin, κ.ά.
Έκδοση: (2018-02-01)

FREQUENCY OF OCCURRENCE OF ANTIBODIES TO HLA ANTIGENS IN RECIPIENTS ON THE WAITING LIST FOR KIDNEY TRANSPLANTATION
ανά: Елена Борисовна Лукоянычева, κ.ά.
Έκδοση: (2023-02-01)

The morphological changes dynamics of ovarian reproductive apparatus in the experimental autoimmune oophoritis
ανά: M. L. Dmitriyeva, κ.ά.
Έκδοση: (2012-02-01)

The Value of the Effect of the Level of Specific Antibodeis on Elimination Different Tick-Borne Encephalitis Virus Strains
ανά: G. N. Leonova, κ.ά.
Έκδοση: (2017-04-01)

Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development
ανά: A. A. Lidzhieva, κ.ά.
Έκδοση: (2018-02-01)

The State of Specific Immunity to Measles and Rubella Virus in Newborns and their mothers
ανά: N. T. Tikhonova, κ.ά.
Έκδοση: (2017-12-01)

Construction and Investigation of the Variants of the Vaccine Strain <I>Francisella tularensis</I> Lacking <I>iglC </I>Genes. Communication 2
ανά: A. N. Mokrievich, κ.ά.
Έκδοση: (2013-12-01)

Donor – recipient selection using epitope mismatches in kidney transplantation
ανά: A. V. Vatazin, κ.ά.
Έκδοση: (2021-01-01)

Improvement of Diagnostic System in a Real-Time RT-PCR “AmpliSens EBOV (ZAIRE)-FL” Format for Zaire ebolavirus RNA Detection
ανά: V. G. Dedkov, κ.ά.
Έκδοση: (2015-09-01)

Construction and Approval of the Test-System for the Detection of Antibodies to Anthrax Agent Using Indirect Fluorescent Immunoassay
ανά: L. Yu. Aksenova, κ.ά.
Έκδοση: (2013-12-01)

Antikeratin antibodies in rheumatoid arthritis
ανά: J Zabek
Έκδοση: (2003-02-01)

Заболявания, свързани с анти-миелинови олигодендроцитни гликопротеинови антитела (MOG-antibody diseases)
ανά: Sonia Ivanova, κ.ά.
Έκδοση: (2019-09-01)

The possible role of toxoplasmosis in the development of antiphospholipid antibodies in pregnancy-related complications
ανά: - Bayati Ali Hattem Hussein, κ.ά.
Έκδοση: (2012-09-01)

Studies of Ebola Virus persistence in the Body Fluids of a Patient at Advanced Stages of Convalescence
ανά: A. A. Lopatin, κ.ά.
Έκδοση: (2015-09-01)

Future Developments and Applications of the Vaccines against Dangerous Viral Infections, RNA-Replicon-Based, Obtained from the Venezuelan Equine Encephalomyelitis Virus
ανά: A. A. Petrov, κ.ά.
Έκδοση: (2014-09-01)